• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.头孢泊肟、头孢克肟和头孢曲松的抗菌活性。
Antimicrob Agents Chemother. 1988 Dec;32(12):1896-8. doi: 10.1128/AAC.32.12.1896.
2
Cefpodoxime: comparative antibacterial activity, influence of growth conditions, and bactericidal activity.头孢泊肟:比较抗菌活性、生长条件的影响及杀菌活性。
Infection. 1991 Sep-Oct;19(5):370-6. doi: 10.1007/BF01645371.
3
In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.口服亚胺甲氧基氨噻唑基头孢菌素R-3746的体外活性
Antimicrob Agents Chemother. 1988 May;32(5):671-7. doi: 10.1128/AAC.32.5.671.
4
Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil.头孢泊肟与头孢克肟、头孢地尼、头孢他美、头孢布烯、氯碳头孢、头孢丙烯、BAY 3522、头孢呋辛、头孢克洛和头孢羟氨苄的抗菌活性比较。
Infection. 1991 Sep-Oct;19(5):353-62. doi: 10.1007/BF01645369.
5
In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime.新型广谱、β-内酰胺酶稳定口服头孢菌素——头孢克肟的体外活性
Pediatr Infect Dis J. 1987 Oct;6(10):958-62. doi: 10.1097/00006454-198710000-00034.
6
Comparative antimicrobial spectrum and activity of ceftibuten against clinical isolates from West Germany.头孢布烯对来自西德临床分离株的抗菌谱及活性比较
Diagn Microbiol Infect Dis. 1991 Jan-Feb;14(1):63-74. doi: 10.1016/0732-8893(91)90091-s.
7
In vitro activity and beta-lactamase stability of FK-037, a parenteral cephalosporin.注射用头孢菌素FK-037的体外活性及β-内酰胺酶稳定性
Antimicrob Agents Chemother. 1993 Mar;37(3):566-73. doi: 10.1128/AAC.37.3.566.
8
In vitro activity of cefpodoxime and ten other cephalosporins against gram-positive cocci, Enterobacteriaceae and Pseudomonas aeruginosa, including beta-lactamase producers.
Infection. 1991 Sep-Oct;19(5):363-9. doi: 10.1007/BF01645370.
9
In vitro activity of a new cephalosporin ME-1206 compared with other agents.新型头孢菌素ME-1206与其他药物的体外活性比较。
Diagn Microbiol Infect Dis. 1991 Sep-Oct;14(5):417-24. doi: 10.1016/0732-8893(91)90068-q.
10
In vitro activity of cefixime, a new oral cephalosporin.新型口服头孢菌素头孢克肟的体外活性
Chemioterapia. 1988 Dec;7(6):365-8.

引用本文的文献

1
Navigating the Muddled Middle: A Case-Based Exploration of Oral β-Lactams for Systemic Gram-Negative Infections.探索复杂的中间地带:基于病例探讨口服β-内酰胺类药物治疗全身性革兰氏阴性菌感染
Open Forum Infect Dis. 2025 Sep 3;12(9):ofaf435. doi: 10.1093/ofid/ofaf435. eCollection 2025 Sep.
2
Cefazolin as a predictor of urinary cephalosporin activity in indicated Enterobacterales.头孢唑林对有指征的肠杆菌科细菌尿液头孢菌素活性的预测作用。
J Clin Microbiol. 2024 Apr 10;62(4):e0078821. doi: 10.1128/jcm.00788-21. Epub 2024 Mar 8.
3
Chitosan-based electrospun nanofibrous mats, hydrogels and cast films: novel anti-bacterial wound dressing matrices.基于壳聚糖的电纺纳米纤维垫、水凝胶和流延膜:新型抗菌伤口敷料基质。
J Mater Sci Mater Med. 2015 Mar;26(3):136. doi: 10.1007/s10856-015-5462-y. Epub 2015 Feb 26.
4
Spectrofluorimetric determination of cefixime using terbium-danofloxacin probe.利用铽-丹氟沙星探针的光谱荧光法测定头孢克肟。
Iran J Basic Med Sci. 2014;17(4):256-62.
5
Antimicrobial activity of DU-6681a, a parent compound of novel oral carbapenem DZ-2640.新型口服碳青霉烯类药物DZ-2640的母体化合物DU-6681a的抗菌活性
Antimicrob Agents Chemother. 1997 Jun;41(6):1260-8. doi: 10.1128/AAC.41.6.1260.
6
Penetration of ceftriaxone (1 or 2 grams intravenously) into mediastinal and cardiac tissues in humans.头孢曲松(静脉注射1或2克)在人体纵隔和心脏组织中的渗透情况。
Antimicrob Agents Chemother. 1996 Mar;40(3):812-5. doi: 10.1128/AAC.40.3.812.
7
Penetration of cefpodoxime into uterine and vaginal secretions from postpartum women after a single oral dose of cefpodoxime proxetil.单次口服头孢泊肟酯后头孢泊肟在产后妇女子宫和阴道分泌物中的渗透情况。
Antimicrob Agents Chemother. 1996 Aug;40(8):1832-4. doi: 10.1128/AAC.40.8.1832.
8
Concentrations of ceftriaxone (1,000 milligrams intravenously) in abdominal tissues during open prostatectomy.开放性前列腺切除术中腹部组织中头孢曲松的浓度(静脉注射1000毫克)。
Antimicrob Agents Chemother. 1996 May;40(5):1311-3. doi: 10.1128/AAC.40.5.1311.
9
Shedding of Clostridium difficile, fecal beta-lactamase activity, and gastrointestinal symptoms in 51 volunteers treated with oral cefixime.51名口服头孢克肟志愿者的艰难梭菌脱落、粪便β-内酰胺酶活性及胃肠道症状
Antimicrob Agents Chemother. 1993 Jul;37(7):1432-5. doi: 10.1128/AAC.37.7.1432.
10
Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potential.头孢克肟。其抗菌活性、药代动力学特性及治疗潜力综述。
Drugs. 1989 Oct;38(4):524-50. doi: 10.2165/00003495-198938040-00004.

本文引用的文献

1
MBCs for Staphylococcus aureus as determined by macrodilution and microdilution techniques.采用常量稀释法和微量稀释法测定的金黄色葡萄球菌的最低杀菌浓度。
Antimicrob Agents Chemother. 1984 Aug;26(2):214-9. doi: 10.1128/AAC.26.2.214.
2
Studies on orally active cephalosporin esters.
J Antibiot (Tokyo). 1987 Mar;40(3):370-84. doi: 10.7164/antibiotics.40.370.
3
In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.新型口服头孢菌素CS-807的体外和体内抗菌活性
Antimicrob Agents Chemother. 1987 Jul;31(7):1085-92. doi: 10.1128/AAC.31.7.1085.
4
In vitro activity of U-76,252 (CS-807), a new oral cephalosporin.新型口服头孢菌素U-76,252(CS-807)的体外活性
Antimicrob Agents Chemother. 1988 Jul;32(7):1082-5. doi: 10.1128/AAC.32.7.1082.

头孢泊肟、头孢克肟和头孢曲松的抗菌活性。

Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.

作者信息

Knapp C C, Sierra-Madero J, Washington J A

机构信息

Department of Microbiology, Cleveland Clinic Foundation, Ohio 44195.

出版信息

Antimicrob Agents Chemother. 1988 Dec;32(12):1896-8. doi: 10.1128/AAC.32.12.1896.

DOI:10.1128/AAC.32.12.1896
PMID:3245701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC176041/
Abstract

Cefpodoxime, cefixime, and ceftriaxone inhibited Branhamella catarrhalis at less than or equal to 1 microgram/ml, beta-hemolytic streptococci at less than or equal to 0.25 microgram/ml, Neisseria meningitidis at less than or equal to 0.06 microgram/ml, and Haemophilus influenzae (other than beta-lactamase-negative, ampicillin-resistant isolates) at less than or equal to 0.12 microgram/ml. The MICs for 50% of isolates of the family Enterobacteriaceae other than Citrobacter freundii, Enterobacter aerogenes, and Enterobacter cloacae were less than or equal to 1 microgram/ml for all three cephalosporins. The MICs of each cephalosporin for 90% of staphylococci, enterococci, and Pseudomonas aeruginosa isolates were greater than 16 micrograms/ml. Inoculum effects were noted with cefpodoxime and cefixime with beta-lactamase-positive H. influenzae.

摘要

头孢泊肟、头孢克肟和头孢曲松对卡他莫拉菌的抑菌浓度小于或等于1微克/毫升,对β溶血性链球菌的抑菌浓度小于或等于0.25微克/毫升,对脑膜炎奈瑟菌的抑菌浓度小于或等于0.06微克/毫升,对流感嗜血杆菌(β内酰胺酶阴性、氨苄西林耐药菌株除外)的抑菌浓度小于或等于0.12微克/毫升。除弗氏柠檬酸杆菌、产气肠杆菌和阴沟肠杆菌外,三种头孢菌素对50%的肠杆菌科菌株的最低抑菌浓度均小于或等于1微克/毫升。每种头孢菌素对90%的葡萄球菌、肠球菌和铜绿假单胞菌菌株的最低抑菌浓度均大于16微克/毫升。头孢泊肟和头孢克肟对β内酰胺酶阳性流感嗜血杆菌有接种物效应。